✦ LIBER ✦

Salvage therapy of aggressive non-Hodgkin's lymphoma with a combination of vinblastine, bleomycin, and cisplatin

✍ Scribed by Michael P. Corder; Gerald H. Clamon

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 351 KB
Volume: 54
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840715)54:2<202::aid-cncr2820540204>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dexamethasone, etoposide, ifosfamide, an

Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-hodgkin's lymphoma

✍ Nissim Haim; Menachem Ben-Shahar; David Faraggi; Avital Tsuri-Etzioni; Michelle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. This study analyzed the long term results of a combination of dexa-

Combination chemotherapy of MOPP-resista

Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)

✍ Delvyn C. Case Jr.; Charles W. Young; Andburton J. Lee III 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 2 views

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY OF HODGKIN'S DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)

✍ J. H. LIPTON; M. GOSPODAROWICZ; S. REINGOLD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of seconda

Treatment of advanced Hodgkin's disease

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

✍ John G. Krikorian; Carol S. Portlock; Dr. Saul A. Rosenberg 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 2 views

twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was

Serum-soluble Fas level determines clini

Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma

✍ Takeshi Hara; Hisashi Tsurumi; Masao Takemura; Hideko Goto; Toshiki Yamada; Mich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

Different age limits for elderly patient

Different age limits for elderly patients with indolent and aggressive non-Hodgkin lymphoma and the role of relative survival with increasing age : Analysis of a population-based non-Hodgkin lymphoma registry

✍ Eduard Maartense; Hanneke C. Kluin-Nelemans; Saskia le Cessie; Philip M. Kluin; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views